About 400 reports

Global & US Gene Therapy Market Forecast to 2020 ##.

  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • World
  • Market Size

Genetic Disorders ##. ##. ##.

  • Regenerative Medicine
  • APAC
  • World
  • Forecast
  • Market Size

Global Gene Therapy Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in Gene therapy dealmaking ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • Demand

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Market Size
  • Viral and Non-Viral Gene Transfer Methods Advantages
  • GLOBAL GENE THERAPY CLINICAL TRIALS BY THERAPY AREAS; 2017

The genetic therapy has created a new revolution by eradication of harmful disease like cystic fibrosis, STD' s, Parkinson' s disease, Huntington' s disease etc. in way that such disease is not transmitted from one generation to anoth

  • Regenerative Medicine
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Genzyme Corporation
  • Intrexon Corporation

In addition, according to Avert Organization (U. K. ), in 2016, approximately ##. ## million people were found to be suffering from human immunodeficiency virus (HIV), and ## million people died due to HIV-related diseases in 2016.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Market Size

Moreover, government initiatives for speeding the development of drug delivery platforms in order to reduce the disease burden are attributive for industrial growth.

  • Antisense Technology
  • Regenerative Medicine
  • Therapy
  • United States
  • Market Size
  • GLOBAL REGENERATIVE MEDICINE MARKET - PIPELINE PRODUCTS
  • North America Regenerative Medicine Market: Prominent Companies

They are: AAV- based therapy, rare neurological genetic disorders.

  • Regenerative Medicine
  • World
  • Market Size
  • Amgen Inc.
  • Celgene Corporation
  • RECENT STRATEGIC ACQUISITIONS IN GLOBAL CELL AND GENE THERAPY MARKET
  • 4.1.1 Inclusions

LUXTURNA IS THE FIRST FDA-APPROVED GENE THERAPY FOR A GENETIC DISEASE.

  • Colorectal Cancer
  • Regenerative Medicine
  • World
  • Market Size
  • Novartis AG
  • Hemophilia Gene Therapy Candidates (2017/2018)
  • 4.2 Key Trends & Development

Gene therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.

  • Regenerative Medicine
  • United States
  • World
  • Bayer AG
  • CSL Limited

THE REPOSITORY CONTAINS MORE THAN ##, ## CELL LINES AND ##, ## DNA SAMPLES FROM HEALTHY INDIVIDUALS AS WELL AS INDIVIDUALS WITH GENETIC DISEASES.

  • Cell Therapy
  • Hospital
  • Regenerative Medicine
  • Research And Development
  • Tissue Banking
  • HEADING:

Cancer is one of the biggest life-threatening diseases across the globe and has been a huge point of concern for the healthcare providers.

  • Colorectal Cancer
  • Pharmaceutical
  • Regenerative Medicine
  • Forecast
  • Celgene Corporation

Researchers have found that heart-on-chip can be adopted to model human genetic diseases or to screen for an individual' s reaction to drugs.

  • Regenerative Medicine
  • World
  • AstraZeneca PLC
  • Nortis, Inc.
  • Roche Group

Rising number of gene therapy-based discovery programs in the pharma industry is one of the key trends driving the production of gene therapy vectors.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • Market Size

The market’s projected growth stems from factors such as the rising prevalence of various diseases such as cancer, infectious diseases, and other genetic disorders, the growing trend toward gene therapy owing to their promising clinical results, and increasing par

  • Colorectal Cancer
  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World

MARKET ##.

  • Medical Biotechnology
  • Regenerative Medicine
  • World

Gene therapy development is aimed to cure rare diseases and even some hereditary diseases, which are caused by a mutated or faulty gene.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • Market Size

TABLE ##.

  • Regenerative Medicine
  • Forecast
  • Market Size
  • Admedus Ltd
  • Biologics, Inc.

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Africa
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • China
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • India
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Germany
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • France
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Brazil
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Saudi Arabia
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Russia
  • Market Size

Genetic Diseases ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Ireland
  • Market Size

NORTH AMERICA CELL EXPANSION MARKET FIGURE ##: NORTH AMERICA DISEASES OUTLOOK ## Millions of Americans are Suffering With Auto- Immune Diseases. ## Millions of Americans Have At least One Chronic Disease. ## new cases of hemophilia due to FVIII added in 2017 in Canada.

  • Diabetes
  • Regenerative Medicine
  • North America
  • World
  • Becton Property Group

Moreover, rising prevalence of inheritable genetic diseases is anticipated to fuel the demand in the field of biotechnology field.

  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • Forecast
  • Market Size